GI probiotic product inventor wins $18M in false advertising suit — 3 insights

A federal jury awarded Claudio De Simone, MD, $18 million after they ruled VSL Pharmaceuticals created an unauthorized copycat product and tried to sell it without clinically testing it.

Advertisement

What you should know:

1. Dr. De Simone created his probiotic product, VSL#3, while working at VSL Pharmaceuticals. The company later allegedly created a copycat of VSL#3 and began selling it.

2. Dr. De Simone never revealed the product’s proprietary formula to VSL Pharmaceuticals. In court, he was able to prove VSL created the copycat product and sold it before clinically testing it.

3. Dr. De Simone has since left VSL Pharmaceuticals and partnered with a new pharmaceutical company.

More articles on surgery centers: 
Virginia medical park with surgery center leases space — 3 insights
Key-Whitman Eye Center’s Dr. Jeffrey Whitman providing eye care to those in need — 4 insights
15 ASC benchmarks to know on ASC nurse staffing

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.